Norges Bank’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,294
Closed -$295K 1757
2025
Q1
$295K Buy
+44,294
New +$438K ﹤0.01% 1716
2024
Q4
Sell
-159,094
Closed -$2.94M 1892
2024
Q3
$2.94M Buy
159,094
+124,342
+358% +$2.55M ﹤0.01% 1607
2024
Q2
$748K Sell
34,752
-26,099
-43% -$599K ﹤0.01% 1845
2024
Q1
$1.64M Sell
60,851
-182,500
-75% -$5.18M ﹤0.01% 1755
2023
Q4
$7.29M Hold
243,351
﹤0.01% 1585
2023
Q3
$4.99M Hold
243,351
﹤0.01% 1674
2023
Q2
$4.84M Hold
243,351
﹤0.01% 1727
2023
Q1
$4.17M Sell
243,351
-77,422
-24% -$1.52M ﹤0.01% 1807
2022
Q4
$6.28M Hold
320,773
﹤0.01% 1711
2022
Q3
$5.12M Hold
320,773
﹤0.01% 1757
2022
Q2
$4.41M Sell
320,773
-7,800
-2% -$93K ﹤0.01% 1796
2022
Q1
$5.21M Sell
328,573
-154,206
-32% -$2.66M ﹤0.01% 1859
2021
Q4
$10.5M Buy
482,779
+151,100
+46% +$4.12M ﹤0.01% 1743
2021
Q3
$9.91M Sell
331,679
-9,633
-3% -$351K ﹤0.01% 1771
2021
Q2
$15.1M Buy
341,312
+13,302
+4% +$578K ﹤0.01% 1648
2021
Q1
$14.6M Buy
328,010
+303,010
+1,212% +$16.6M ﹤0.01% 1664
2020
Q4
$1.37M Buy
+25,000
New +$911K ﹤0.01% 1994

Other funds holding RCKT